-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
Healthcare AI Shakeout: Health Systems Plan to Cut AI Vendors Nearly in Half by 2028, Black Book Finds
-
Sparta Capital Ltd. Announces Resumption of Trading
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
CORRECTION FROM SOURCE: Nixxy Announces 1-for-20 Reverse Stock Split
-
Olenox Secures Texas Pipeline Operating Permit, Clearing Path for Initial 4 MW Power Deployment
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
'Severe' pain: a New Yorker's experience of monkeypox
"It was the worst pain that I have experienced in my life," says 26-year-old New Yorker Kyle Planck, recalling his recent monkeypox infection.
Although anyone can catch monkeypox, Planck first took note of the virus in spring when authorities said many of the first cases in Europe and America were in men who have sex with men.
"I was a little bit worried that it would eventually affect us here in the United States, especially being a member of the LGBTQ+ community," he remembers.
At the end of June, the PhD candidate in pharmacology says he started to feel very sick.
A fever, swollen lymph nodes and a negative Covid-19 test made him think it could be monkeypox.
A doctor told him to wait and see how his symptoms evolved, but after four days of being feverish he developed spots that left him in no doubt.
"They had started on my arms and my hands and over the course of a day they spread all over my body.
"I had about 30 lesions develop at that point," he says at his apartment in the borough of Queens.
Planck was able to get tested on July 5 and the following day started treatment with TPOXX, or Tecovirimat, an antiviral drug originally used against human smallpox but authorized in a trial against monkeypox.
Planck concedes that his proximity to the medical community made it easier for him to enroll in a study.
"I know that is not the reality for most people in New York, which is really unfortunate," he says.
Monkeypox usually clears up on its own but can be extremely painful.
Planck was in intense pain for a week, especially from the lesions on his mucus membranes, before the drugs started to relieve his symptoms.
"The pain was so severe for me that I basically was taking warm baths six or seven times a day, just because that was the only thing that would make me feel better," he says.
Planck found the experience "exhausting" and adding to his stress was a fear of contaminating his roommate, even though transmission occurs by close contact.
He believes his case was "relatively mild" because he was able to receive treatment and that "so many people are going through worse."
Planck feels that US health authorities were too slow to react to the first outbreak of cases and says that preventative messaging has been too weak.
- Vaccine doses -
"I think the government was kind of like, 'let's wait and see what happens, let's wait and see if this becomes a problem,' and that really doesn't take into account how infectious diseases work," he says.
Planck has written multiple letters to elected officials asking them to increase access to the antiviral drug.
"We have millions of doses of the TPOXX treatment available. And months into this outbreak, we're still not really able to mobilize those resources," he says.
The United States initially had 100 million doses of the ACAM2000 vaccine. It is designed to treat human smallpox but can cause significant side effects and is not recommended for immunocompromised people.
Only a thousand doses of the newer and safer Jynneos vaccine were available as cases first started multiplying, largely because nearly 800,000 doses were blocked in Denmark pending approval by the Food and Drug Administration.
Availability is increasing, however.
New York City -- which has 711 confirmed cases, the highest concentrated number in the country -- has received 21,500 doses and is awaiting a supply of 25,000 more.
Appointments have gone in minutes and long queues have formed outside clinics in recent days.
"I don't want anyone to have to go through what I went through," concludes Planck.
F.Wilson--AT